Rising prevalence of infectious diseases and increasing focus on production of therapeutic antibodies for treating cancer and other chronic diseases are key factors boosting global market growth
Market size: USD 12.56 Billion in 2020, Market Growth: CAGR of 13.1%, Market Trends: High demand for protein therapeutics
The global antibody production market size is expected to reach USD 33.52 Billion in 2028 and register a CAGR of 13.1%, according to the latest report by Reports and Data. Key factors such as rising investments in research and development activities and increasing demand for cost-effective therapeutic treatments are boosting global market revenue growth.
Antibodies are extensively used in diagnostics, research, and therapeutic purposes due to key features such as high specificity, binding affinity, and low toxicity. The global antibody production market is driven by key factors including patent cessation of monoclonal antibodies, gradual government acceptance for various targeted immunotherapy, and antibody therapeutics to treat several chronic diseases like cancer, and rheumatic arthritis. Rapid growth in the pharmaceutical and biotechnology sector, growing adoption of protein therapeutics, and availability of enhanced technology for antibody production are also fueling global market growth.
However, factors such as costly primary antibodies and a low number of commercially available antibody drugs are expected to hamper overall market growth during the forecast period.
Get a sample of the report @ https://www.reportsanddata.com/discount-enquiry-form/1404
The rapid adoption of AI, ML, and IoT and robust data management processes has made the hospitals and clinical settings smarter. New technologies and solutions have improved the normal medical processes such as clinical diagnosis, treatment, diseases management, and monitoring patient recovery after discharge. Rapid digitalization and increasing adoption of virtual care and telemedicine is further expected to positively impact the revenue growth of the market going ahead.
Emergence of new healthcare and telemedicine startups, increasing number of collaborations among healthcare facilities and research institutions, and rising focus on patient engagement solutions has further fueled revenue growth of the market. Key companies are forming strategic alliances and collaborative ventures such as mergers and acquisitions, joint ventures, partnerships, manufacturing and licensing agreements, and product launches among others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1404
Leading Players Analyzed in the Report:
Thermo Fisher Scientific, Inc., GE Healthcare, Sartorius AG, Merck KGaA, Eppendorf AG, Cellab GmbH, Pall Corp., INTEGRA Biosciences AG, FiberCell Systems Inc GeneTex, Inc., Eli Lilly and Company, Pall Corporation, Merck KGaA, Eppendorf AG, Abcam PLC, and Sigma Aldrich Corporation
Furthermore, to offer a better understanding of the competitive landscape, an extensive SWOT analysis and Porter’s Five Forces analysis are included in the report. Along with this, feasibility analysis and investment return analysis are also covered in the report.
The report further discusses in detail the regional spread of the global Antibody Production market along with analysis of production and consumption patterns, import/export analysis, supply and demand ratio, market share and size based on volume and value, trends and demands, revenue share, and presence of the key players of the market.
To know more about the report @ https://www.reportsanddata.com/report-detail/antibody-production-market
Key Regions Studied in the Report:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, France, Rest of Europe)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Segmentation based on Types:
Class Outlook (Revenue, USD Billion, 2020 – 2028)
- Monoclonal antibodies
- Polyclonal Antibodies
Process Outlook (Revenue, USD Billion, 2020 – 2028)
- Upstream Processing
- Large-scale bioreactors
- Single-use bioreactors
- Buffers and Reagents
- Downstream Processing
- Chromatography Systems
- Chromatography Resins
- Filtration Systems
- Filtration Consumables and Accessories
End-Use Outlook (Revenue, USD Billion, 2020 – 2028)
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- Research Institutes
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1404
Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements.
Read More Related Reports:-
Browse More Reports:
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370